Weight-loss drug manufacturer Novo Nordisk cuts 9000 jobs — and its profit forecast

New CEO Mike Doustdar is kitchen-sinking the costs of restructuring the company to focus on diabetes and anti-obesity drugs.

Previous Article

Lebanese Government Commits To "Fully Disarming" Hezbollah

Next Article

Poland Seals Border With Belarus, Bracing For Russia's 'Zapad' War Games

Write a Comment

Leave a Comment

Your email address will not be published. Required fields are marked *

− 1 = 1
Powered by MathCaptcha

Subscribe to our Newsletter

Subscribe to our email newsletter to get the latest posts delivered right to your email.
Pure inspiration, zero spam ✨